Clinical Trial Update: The Effect of Erythropoietin Usage in Renal Function After Kidney Transplantation, in Early Phase, in Contrast to Placebo Group [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating erythropoietin to improve renal function after kidney transplantation, compared with placebo.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: Labbafinejhad Hospital | Conditions: Transplantation, Kidney | Phase 1 | Status: UNKNOWN